Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism IKKα inhibitors(component of inhibitor of nuclear factor kappa B kinase complex inhibitors), IKKβ inhibitors(inhibitor of nuclear factor kappa B kinase subunit beta inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC15H16N2O |
InChIKeyCPCZNJSFVOOZOG-UHFFFAOYSA-N |
CAS Registry200134-22-1 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Inflammation | Preclinical | AT | 29 Jan 2019 |